LIMA ROGEL, MA. VICTORIA
ESPECIALIDAD MÉDICA · Nivel 2
Desde 1991 es en Hospital Central Dr Ignacio Morones Prieto
Neonatology Pediatrician Master Degree Molecular Biology Professor Researcher
Neonatology
Pediatrician
Master Degree Molecular Biology
Professor
Researcher
| Nombre | MA. VICTORIA LIMA ROGEL |
|---|---|
| Área | MEDICINA Y CIENCIAS DE LA SALUD |
| Campo | ESPECIALIDAD MÉDICA |
| Disciplina | NEONATOLOGÍA |
| Especialidad | NEONATOLOGIA |
| CVU | 122919 |
| Institución | |
|---|---|
| Dependencia | COORDINACION ESTATAL DE LOS SERVICIOS DE SALUD (IMSS-BIENESTAR) S.L.P. |
| Entidad | SAN LUIS POTOSI |
| Nivel | 2 |
| Vigencia | Inicio: 01/01/2024 |
| Fin: 31/12/2028 |
Publicaciones ORCID
- 2026
- Population pharmacokinetics and dose optimization of piperacillin-tazobactam in premature and term neonates with severe infections Antimicrobial Agents and Chemotherapy
- 2024
- XIII Consenso SIBEN sobre Traslado Neonatal: Establecer protocolos estructurados para el proceso del traslado neonatal podría mejorar los desenlaces NeoReviews
- External Evaluation of Population Pharmacokinetic Models of Piperacillin in Preterm and Term Patients from Neonatal Intensive Care European Journal of Drug Metabolism and Pharmacokinetics
- Association Between Pro-inflammatory Cytokine Levels (IL-1β, IL-6, and TNF-α) in Human Colostrum and Maternal Body Composition Components Breastfeeding Medicine
- The Urinary Metabolome of Newborns with Perinatal Complications Metabolites
- 2022
- Incidence of congenital and postnatal cytomegalovirus infection during the first year of life in Mexican preterm infants Journal of Medical Virology
- 2021
- Urinary Metabolomic Profile of Neonates Born to Women with Gestational Diabetes Mellitus Metabolites
- Optimizing Meropenem Therapy for Severe Nosocomial Infections in Neonates Journal of Pharmaceutical Sciences
- Perinatal COVID-19: a case report, literature review, and proposal of a national system for case record Boletín Médico del Hospital Infantil de México
- A global point prevalence survey of antimicrobial use in neonatal intensive care units: The no-more-antibiotics and resistance (NO-MAS-R) study EClinicalMedicine